QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 19 April 2005
doi: 10.1242/jcs.02339

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jcs.02339v1 118/9/2057    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hsiao, V. C. Articles by Goldman, J. E. Search for Related Content PubMed PubMed Citation Articles by Hsiao, V. C. Articles by Goldman, J. E. Social Bookmarking                         What's this?

Alexander-disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP

¹ Department of Pathology and the Center for Neurobiology and Behavior, Columbia University, New York, NY 10032, USA
² School of Biological and Medical Sciences, University of Durham, Durham, DH1 3LE, UK
³ Department of Neurobiology, and The Civitan International Research Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA

^* Author for correspondence (e-mail: jeg5{at}columbia.edu)

Accepted 31 January 2005

Alexander disease is a fatal neurological illness characterized by white-matter degeneration and the formation of astrocytic cytoplasmic inclusions called Rosenthal fibers, which contain the intermediate filament glial fibrillary acidic protein (GFAP), the small heat-shock proteins HSP27 and B-crystallin, and ubiquitin. Many Alexander-disease patients are heterozygous for one of a set of point mutations in the GFAP gene, all of which result in amino acid substitutions. The biological effects of the most common alteration, R239C, were tested by expressing the mutated protein in cultured cells by transient transfection. In primary rat astrocytes and Cos-7 cells, the mutant GFAP was incorporated into filament networks along with the endogenous GFAP and vimentin, respectively. In SW13Vim^– cells, which have no endogenous cytoplasmic intermediate filaments, wild-type human GFAP frequently formed filamentous bundles, whereas the R239C GFAP formed `diffuse' and irregular patterns. Filamentous bundles of R239C GFAP were sometimes formed in SW13Vim^– cells when wild-type GFAP was co-transfected. Although the presence of a suitable coassembly partner (vimentin or GFAP) reduced the potential negative effects of the R239C mutation on GFAP network formation, the mutation affected the stability of GFAP in cells in a dominant fashion. Extraction of transfected SW13Vim^– cells with Triton-X-100-containing buffers showed that the mutant GFAP was more resistant to solubilization at elevated KCl concentrations. Both wild-type and R239C GFAP assembled into 10 nm filaments with similar morphology in vitro. Thus, although the R239C mutation does not appear to affect filament formation per se, the mutation alters the normal solubility and organization of GFAP networks.

Key words: Intermediate filaments, Alexander disease, GFAP, Cytoskeleton

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T. L. Hagemann, W. C. Boelens, E. F. Wawrousek, and A. Messing Suppression of GFAP toxicity by {alpha}B-crystallin in mouse models of Alexander disease Hum. Mol. Genet., April 1, 2009; 18(7): 1190 - 1199. [Abstract] [Full Text] [PDF]

				G. Tang, Z. Yue, Z. Talloczy, T. Hagemann, W. Cho, A. Messing, D. L. Sulzer, and J. E. Goldman Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways Hum. Mol. Genet., June 1, 2008; 17(11): 1540 - 1555. [Abstract] [Full Text] [PDF]

				J. Zhai, H. Lin, J.-P. Julien, and W. W. Schlaepfer Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charcot Marie Tooth disease-linked mutations in NFL and HSPB1 Hum. Mol. Genet., December 15, 2007; 16(24): 3103 - 3116. [Abstract] [Full Text] [PDF]

				G. Tang, Z. Xu, and J. E. Goldman Synergistic Effects of the SAPK/JNK and the Proteasome Pathway on Glial Fibrillary Acidic Protein (GFAP) Accumulation in Alexander Disease J. Biol. Chem., December 15, 2006; 281(50): 38634 - 38643. [Abstract] [Full Text] [PDF]

				T. L. Hagemann, J. X. Connor, and A. Messing Alexander Disease-Associated Glial Fibrillary Acidic Protein Mutations in Mice Induce Rosenthal Fiber Formation and a White Matter Stress Response J. Neurosci., October 25, 2006; 26(43): 11162 - 11173. [Abstract] [Full Text] [PDF]

				F.J. Wippold II, A. Perry, and J. Lennerz Neuropathology for the neuroradiologist: rosenthal fibers. AJNR Am. J. Neuroradiol., May 1, 2006; 27(5): 958 - 961. [Abstract] [Full Text] [PDF]

				R. Tian, M. Gregor, G. Wiche, and J. E. Goldman Plectin Regulates the Organization of Glial Fibrillary Acidic Protein in Alexander Disease Am. J. Pathol., March 1, 2006; 168(3): 888 - 897. [Abstract] [Full Text] [PDF]